Durso Jerome Benedict 4
4 · Altimmune, Inc. · Filed Mar 9, 2026
Research Summary
AI-generated summary of this filing
Altimmune (ALT) CEO Jerome Durso Buys 20,000 Shares
What Happened
- Durso Jerome Benedict (President, CEO and Director) purchased 20,000 shares of Altimmune, Inc. in open-market transactions on March 6, 2026. The weighted average price reported was $3.54 per share, for a total transaction value of approximately $70,790. This is a purchase (code P).
Key Details
- Transaction date: 2026-03-06; Form 4 filed: 2026-03-09 (appears timely under the two-business-day rule).
- Price: weighted average $3.54; reported price range across multiple trades $3.5300–$3.5500 (see footnote F1).
- Total shares acquired: 20,000; total value ≈ $70,790.
- Shares owned after the transaction: not specified in this filing.
- Footnote: F1 states the $3.54 is a weighted average and the reporter will provide the per-price breakdown on request.
Context
- Open-market purchases by executives are often noted by investors as informative, but the filing does not state the insider’s motivation. No options were exercised and no awards, gifts, or tax-withholding actions are involved in this report.
Insider Transaction Report
Form 4
Durso Jerome Benedict
DirectorPresident and CEO
Transactions
- Purchase
Common Stock, par value $0.0001
[F1]2026-03-06$3.54/sh+20,000$70,790→ 32,500 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.5300 to $3.5500, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Signature
/s/ Gregory Weaver, as Attorney-in-Fact|2026-03-09